{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:34:03Z","timestamp":1794321243669,"version":"4.9.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771010"],"award-info":[{"award-number":["31771010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672803"],"award-info":[{"award-number":["81672803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154108","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:23:15Z","timestamp":1787034195000},"page":"154108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["A novel tumor necrosis factor-alpha-targeting protein degrader for the treatment of acute liver failure"],"prefix":"10.1016","volume":"381","author":[{"given":"Junjie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuochao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154108_bb0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(95)90070-5","article-title":"The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation","volume":"81","author":"Hsu","year":"1995","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154108_bb0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"Van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"26","key":"10.1016\/j.ijbiomac.2026.154108_bb0015","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4 Pt 1","key":"10.1016\/j.ijbiomac.2026.154108_bb0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/jhep.2000.17687","article-title":"The systemic inflammatory response syndrome in acute liver failure","volume":"32","author":"Rolando","year":"2000","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.ijbiomac.2026.154108_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2012.00079","article-title":"Mechanisms of cell death in acute liver failure","volume":"3","author":"Bantel","year":"2012","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154108_bb0030","first-page":"331","article-title":"Immune mechanisms in acetaminophen-induced acute liver failure","volume":"3","author":"Krenkel","year":"2014","journal-title":"Hepatobiliary surgery and nutrition"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154108_bb0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154108_bb0040","first-page":"1220","article-title":"Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models","volume":"146","author":"Leist","year":"1995","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154108_bb0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2017.01.005","article-title":"RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis","volume":"66","author":"Filliol","year":"2017","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154108_bb0050","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154108_bb0055","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"9107","key":"10.1016\/j.ijbiomac.2026.154108_bb0060","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(05)60602-2","article-title":"Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group","volume":"351","author":"Abraham","year":"1998","journal-title":"Lancet (London, England)"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154108_bb0065","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1995.03520360048038","article-title":"Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group","volume":"273","author":"Abraham","year":"1995","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.ijbiomac.2026.154108_bb0070","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group","volume":"334","author":"Fisher C","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154108_bb0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/emmm.201000085","article-title":"Regulation of liver regeneration by growth factors and cytokines","volume":"2","author":"B\u00f6hm","year":"2010","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154108_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40264-015-0366-9","article-title":"Hepatotoxicity associated with the use of anti-TNF-\u03b1 agents","volume":"39","author":"French","year":"2016","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154108_bb0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41573-023-00833-z","article-title":"Extracellular targeted protein degradation: an emerging modality for drug discovery","volume":"23","author":"Wells","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7820","key":"10.1016\/j.ijbiomac.2026.154108_bb0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154108_bb0095","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.0308728100","article-title":"Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice","volume":"101","author":"Lebowitz","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"41","key":"10.1016\/j.ijbiomac.2026.154108_bb0100","doi-asserted-by":"crossref","first-page":"14870","DOI":"10.1073\/pnas.1416660111","article-title":"Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB","volume":"111","author":"Kan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"47","key":"10.1016\/j.ijbiomac.2026.154108_bb0105","doi-asserted-by":"crossref","first-page":"14774","DOI":"10.1002\/anie.201607824","article-title":"Design of Potent Mannose 6-phosphate analogues for the functionalization of lysosomal enzymes to improve the treatment of Pompe disease","volume":"55","author":"El Cheikh","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154108_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977194.2011.640325","article-title":"Biology and significance of signalling pathways activated by IGF-II","volume":"30","author":"Harris","year":"2012","journal-title":"Growth factors (Chur, Switzerland)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154108_bb0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13045-025-01703-4","article-title":"Targeted degradation of extracellular proteins: state of the art and diversity of degrader designs","volume":"18","author":"Mamun","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154108_bb0120","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2415333","article-title":"Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan","volume":"16","author":"Mukai","year":"2024","journal-title":"mAbs"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154108_bb0125","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1093\/rheumatology\/keaf171","article-title":"Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: a post hoc analysis of the OHZORA trial","volume":"64","author":"Watanabe","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154108_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The therapeutic potential of Nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs\u202f: clinical immunotherapeutics, biopharmaceuticals and gene therapy"},{"key":"10.1016\/j.ijbiomac.2026.154108_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150454","article-title":"Structural design of the anti-TNF\u03b1 therapeutic NANOBODY\u00ae compound, ozoralizumab, to support its potent and sustained clinical efficacy","volume":"734","author":"Mima","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154108_bb0140","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1038\/cddis.2011.111","article-title":"TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members","volume":"2","author":"Vanlangenakker","year":"2011","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154108_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12462","article-title":"Milk-derived extracellular vesicles functionalized with anti-tumour necrosis factor-\u03b1 nanobody and anti-microbial peptide alleviate ulcerative colitis in mice","volume":"13","author":"Jing","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154108_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027287","article-title":"Protein replacement therapy partially corrects the cholesterol-storage phenotype in a mouse model of Niemann-pick type C2 disease","volume":"6","author":"Nielsen","year":"2011","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.ijbiomac.2026.154108_bb0155","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1073\/pnas.0807328105","article-title":"NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes","volume":"105","author":"Infante","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154108_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700686","article-title":"Bioprocessing of recombinant CHO-K1, CHO-DG44, and CHO-S: CHO expression hosts favor either mAb production or biomass synthesis","volume":"14","author":"Reinhart","year":"2019","journal-title":"Biotechnol. J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154108_bb0165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.sbi.2009.09.002","article-title":"Carbohydrate recognition by the mannose-6-phosphate receptors","volume":"19","author":"Kim","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154108_bb0170","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/sj.emboj.7600215","article-title":"Structure of uPAR, plasminogen, and sugar-binding sites of the 300 kDa mannose 6-phosphate receptor","volume":"23","author":"Olson L","year":"2004","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154108_bb0175","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1006\/cyto.1998.0492","article-title":"Modes of L929 cell death induced by TNF-alpha and other cytotoxic agents","volume":"11","author":"Humphreys","year":"1999","journal-title":"Cytokine"},{"issue":"5288","key":"10.1016\/j.ijbiomac.2026.154108_bb0180","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.274.5288.787","article-title":"Suppression of TNF-alpha-induced apoptosis by NF-kappaB","volume":"274","author":"Van Antwerp","year":"1996","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154108_bb0185","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1021\/pr0701759","article-title":"Identification of novel molecular candidates for acute liver failure in plasma of BALB\/c murine model","volume":"6","author":"Lv","year":"2007","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154108_bb0190","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/SHK.0000000000000239","article-title":"Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine\/lipopolysaccharide-induced acute liver failure","volume":"42","author":"Shirozu","year":"2014","journal-title":"Shock (Augusta, Ga)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154108_bb0195","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1210\/endo-128-2-1201","article-title":"[Leu27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experiments","volume":"128","author":"Beukers","year":"1991","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154108_bb0200","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.165.3.657","article-title":"Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice","volume":"165","author":"lehmann","year":"1987","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154108_bb0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0006-2952(89)90208-6","article-title":"Tumor necrosis factor is a terminal mediator in galactosamine\/endotoxin-induced hepatitis in mice","volume":"38","author":"Tiegs","year":"1989","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154108_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.036","article-title":"A quantitative proteome map of the human body","volume":"183","author":"Jiang","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154108_bb0215","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/acs.biochem.2c00310","article-title":"Targeted protein degradation via lysosomes","volume":"62","author":"Paudel","year":"2023","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154108_bb0220","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.7150\/thno.30972","article-title":"A novel TNF-\u03b1-targeting aptamer for TNF-\u03b1-mediated acute lung injury and acute liver failure","volume":"9","author":"Lai","year":"2019","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154108_bb0225","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.4103\/NRR.NRR-D-24-00667","article-title":"Aptamers as new promising entities for therapeutics: our experience from the neurological diseases","volume":"20","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijbiomac.2026.154108_bb0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2018.10.008","article-title":"Pharmacokinetics, pharmacodynamics and safety of aptamers","volume":"134","author":"Kovacevic","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154108_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107944","article-title":"Extracellular RNA drives TNF-\u03b1\/TNF-receptor-1 mediated cardiac ischemia\/reperfusion injury: mechanistic insights and therapeutic potential of RNase1","volume":"221","author":"Cabrera-Fuentes","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"5500","key":"10.1016\/j.ijbiomac.2026.154108_bb0240","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1126\/science.290.5500.2298","article-title":"Identification of HE1 as the second gene of Niemann-pick C disease","volume":"290","author":"Naureckiene","year":"2000","journal-title":"Science (New York, N.Y.)"},{"issue":"4844","key":"10.1016\/j.ijbiomac.2026.154108_bb0245","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.2964083","article-title":"A single receptor binds both insulin-like growth factor II and mannose-6-phosphate","volume":"239","author":"Macdonald","year":"1988","journal-title":"Science (New York, N.Y.)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154108_bb0250","first-page":"4266","volume":"85","author":"Ong","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154108_bb0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cytogfr.2008.01.005","article-title":"IGF2: epigenetic regulation and role in development and disease","volume":"19","author":"Chao","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.154108_bb0260","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2320053121","article-title":"Directed evolution of genetically encoded LYTACs for cell-mediated delivery","volume":"121","author":"Yang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8051","key":"10.1016\/j.ijbiomac.2026.154108_bb0265","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","article-title":"Designed endocytosis-inducing proteins degrade targets and amplify signals","volume":"638","author":"Huang","year":"2025","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154108_bb0270","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154108_bb0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13075-023-03036-4","article-title":"Efficacy and pharmacokinetics of ozoralizumab, an anti-TNF\u03b1 NANOBODY(\u00ae) compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials","volume":"25","author":"Takeuchi","year":"2023","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154108_bb0280","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaci.2020.07.015","article-title":"Neonatal fc receptor in human immunity: function and role in therapeutic intervention","volume":"146","author":"Patel","year":"2020","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026040547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026040547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:20:38Z","timestamp":1794320438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026040547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0141813026040547"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154108","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel tumor necrosis factor-alpha-targeting protein degrader for the treatment of acute liver failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154108"}}